TOPICAL FORMS OF INTERFERON ALPHA-2B WITH ANTIOXIDANTS FOR ARI PROPHYLAXIS IN MILITARY BODIES UNDER COVID-19 PANDEMIC

The aim of the work was to evaluate the epidemiological effectiveness of the topical form of the domestic antiviral drug gel Viferon ® (IFN-a-2b with antioxidants) in organized military training groups for the prevention of SARS in the conditions of the COVID-19 pandemic.

Materials and methods. The authors observed 458 cadets-pupils of the Nakhimov naval school of the Ministry of defense of the Russian Federation.

Conclusion. There was a statistically significant decrease in the incidence of ARVI cadets Nakhimov school in 2020 in April (p<0,001), may (p<0,05) and June (p<0,05) in 2020, which can be explained by the preventive use of the drug Viferon ® (gel).

1. Keshishyan E.S., Zenina O.M., Kushnareva M.V. Local immunoprophylaxis efficacy in case of acute respiratory infection in tender-age infants in general care units. Effective pharmacotherapy, 2013, No. 50, pp. 50–54 (In Russ.).

2. Akimkin V.G., Korotchenko S.I., Shevtsov V.A., Volgin A.R., Salmina T.A., Kalabukhova L.Yu., Malinovskaya V.V., Gatich R.Z., Semenenko T.A., Guseva T.S., Parshina O.V., Dmitrieva E.V. Epidemiological and immunological effectiveness of the use of the drug Viferon, a gel for the prevention of influenza and other acute respiratory infections in organized military collectives. Epidemiology and infectious diseases. Current issues, 2011, No. 1, рp. 28–36 (In Russ.).

3. Rybin V.V., Sabanin Y.V., Kuzin S.N., Kоs’kiv O.V., Rihter V.V., Zavolokin V.A. Epidemiological characteristics of acute tonsillitis soldiers of internal troops of the MIA of Russia. Military medical journal, 2011, No. 3, рp. 52–55 (In Russ.).

4. Yarilin A.A. Immunology. Moscow, 2010, рр. 218–226 (In Russ.)].

5. Isaacs A., Lindenmann J. Virus interference. I. The interferon // Proc. R. Soc. Lond. B. Biol. Sci. 1957, Vol. 147 (927), рр. 258–267. https:// doi.org/10.1098/rspb.1957.0048.

6. Simonenko V.B., Dulin P.A., Makanin M.A. Possibilities of targeted therapy for neuroendocrine tumors. Clinical medicine, 2014, Vol. 92, No. 8, pp. 5–14 (In Russ.).

7. Khaitov M.R., Shilovsky I.P., Khaitov R.M. Type III interferons. Modern biology success, 2010, T. 130, No. 2, pp. 147–153 (In Russ.).

8. Khaitov R.M. Immunology. Immune system structure and function: textbook. Moscow: GEOTAR-Media, 2013 (In Russ.).

9. Garcia-Sastre A. Induction and evasion of type I interferon responses by influenza viruses // Virus Res. 2011. Vol. 162. Р. 12–18.

10. Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions // Current opinion in virology. 2011. No. 1 (6). Р. 519–525.

11. Kalyuzhin O.V. Rectal and Topical Dosage Forms of Interferon alpha in Acute Respiratory Viral Infection: Searching Answers to Debatable Questions. Allergology and immunology, 2017, Vol. 18, No. 1, рр. 21–25 (In Russ.).

12. Ruzhentsova T.A., Levitskaya D.S. Treatment of acute respiratory viral infections and influenza in children: results of a meta-analysis. Journal of the Attending Physician, 2020, No. 3, рр. 52–57 (In Russ.). doi: 10.26295/OS.2020.93.40.008.

13. Obraztsova E.V., Osidak L.V., Golovacheva E.G., Zarubaev V.V., Afanasieva O.I., Milkint K.K. Viferon gel application in acute respiratory viral infection in children. Pediatrician, 2011, No. II (2), pp. 53–60 (In Russ.).

14. Baranova I.P., Svistunova N.V. Comparative research of antiviral medications efficacy in integrated flu therapy. Infection diseases, 2014, Vol. 12, No. 2, pp. 46–53 (In Russ.).

15. Chebotareva T.A., Mazankova L.N., Malinovskaya V.V., Parfenov V.V., Ulianova I.I. Clinicoimmunological efficacy of local ARVI interferon therapy in children. Modern pediatrics issues, 2007, No. 4, pp. 29–32 (In Russ.).

16. Osidak L.V., Obraztsova E.V., Golovacheva E.G., Afanasieva O.I., Sukhovetskaya V.F., Drinevsky V.P., Kiseleva O.V., Pavlova E.B. VIFERON® in flu and other ARI (of either viral or viral-bacterial etiology) in children. Pediatric infections, 2012, No. 1, pp. 44–49 (In Russ.).